During the corresponding time, Sintx Technologies Inc recorded a revenue increase by 199.34 % year on year, sequentially revenue grew by 18.95 %. While revenue at the Sintx Technologies Inc 's corporate clients
Sintx Technologies Inc's Comment on Sales, Marketing and Customers
SINTX operates in the electrical, aerospace, and industrial sectors, with a primary focus on biomedical applications involving medical-grade silicon nitride. Since 2008, their silicon nitride spinal implants have been used in patients across the United States, Europe, South America, and Asia. The company received FDA 510(k) clearance for the SiNAPTIC® Foot & Ankle Osteotomy Wedge System, allowing entry into reconstructive foot and ankle surgery in the U.S. SINTX's products are also applicable to other fusion devices, including arthroplasty implants, foot wedges, dental implants, and bearings for hip and knee replacements. Additionally, the company incorporates silicon nitride powder into products such as face masks, drapes, filters, sutures, and wound care devices to inactivate pathogens, including SARS-CoV-2. SINTX's manufacturing facility is located in Salt Lake City, Utah, and its products are primarily sold in the United States.
Groundbreaking Study Unveils Broad-Spectrum Antiviral Properties of Silicon Nitride, Paving the Way for Multi-Billion-Dollar Infection-Control MarketsSINTX Technologies, a frontrunner in advanced ceramic materials, has recently unveiled a landmark study that could potentially revolutionize the infection-control sector. The study reveals the broad-spectrum antiviral capabilities of silicon nitride, a material traditionally employed in biomedical implants. This breakthrough has the potential to spearhead novel applications across a variety of high-demand industries, opening the doors to multi-billion-dollar infection-control markets.The transformative study conducted by SINTX Technologies outlines the effecti...
Sintx Technologies Inc’s Comment on Sales, Marketing and Customers
SINTX operates in the electrical, aerospace, and industrial sectors, with a primary focus on biomedical applications involving medical-grade silicon nitride. Since 2008, their silicon nitride spinal implants have been used in patients across the United States, Europe, South America, and Asia. The company received FDA 510(k) clearance for the SiNAPTIC® Foot & Ankle Osteotomy Wedge System, allowing entry into reconstructive foot and ankle surgery in the U.S. SINTX's products are also applicable to other fusion devices, including arthroplasty implants, foot wedges, dental implants, and bearings for hip and knee replacements. Additionally, the company incorporates silicon nitride powder into products such as face masks, drapes, filters, sutures, and wound care devices to inactivate pathogens, including SARS-CoV-2. SINTX's manufacturing facility is located in Salt Lake City, Utah, and its products are primarily sold in the United States.
Sources:
Sintx Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Sintx Technologies Inc’s corporate clients.
For your research, we’ve provided 9 tables on Sintx Technologies Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
165.27 %